GlassScriptPhysician profile
Alex Todd Hirsh
NPI 1174639181
$159,051.92
in general payments reported to CMS, 2019-2025
34 companies · $17K in 2025
The $17K reported for 2025 was more than what 94% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,461 · 2020: $9,889 · 2021: $15K · 2022: $16K · 2023: $46K · 2024: $45K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $99K · Food and Beverage: $4,937 · Travel and Lodging: $4,053 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $99,000.00 |
| Food and Beverage | $4,937.48 |
| Travel and Lodging | $4,053.01 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $129,363.03 | 2019-2025 | Aklief, Epsolay, Oracea |
| Lilly USA, LLC | $26,505.72 | 2019-2025 | Ebglyss, Taltz, Olumiant |
| Abbvie INC. | $688.20 | 2019-2025 | |
| Amgen INC. | $260.39 | 2021-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $253.93 | 2019-2025 | Absorica Ld, Winlevi |
| Janssen Biotech, INC. | $225.82 | 2019-2025 | Tremfya |
| Incyte Corporation | $206.00 | 2021-2024 | Opzelura |
| Dermavant Sciences, INC. | $177.13 | 2023-2024 | Vtama |
| Leo Pharma INC. | $174.04 | 2019-2025 | Adbry |
| Almirall LLC | $109.14 | 2019-2022 | |
| Pfizer INC. | $108.69 | 2019-2025 | |
| Ucb, INC. | $101.73 | 2023-2024 | Bimzelx, Cimzia |
| E.R. Squibb & Sons, L.L.C. | $95.02 | 2023-2024 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $90.14 | 2019-2025 | Cabtreo, Jublia, Arazlo |
| Novartis Pharmaceuticals Corporation | $88.36 | 2019-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.80 | 2023-2024 | Spevigo, Cyltezo |
| Epi Health, LLC | $62.86 | 2019-2022 | |
| Dermira, INC. | $62.58 | 2019-2020 | |
| Organon LLC | $50.55 | 2025 | Vtama |
| Arcutis Biotherapeutics, INC. | $48.76 | 2024 | Zoryve |
| Genzyme Corporation | $43.14 | 2019-2025 | |
| Prugen, INC. Pharmaceuticals | $38.80 | 2019-2020 | |
| Medimetriks Pharmaceuticals, INC. | $28.45 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $27.68 | 2025 | Libtayo |
| Lnhc, INC | $24.83 | 2025 | Zelsuvmi |
| Celgene Corporation | $24.80 | 2019 | |
| Vyne Pharmaceuticals INC. | $20.86 | 2020 | |
| Verrica Pharmaceuticals INC. | $15.81 | 2023 | Ycanth |
| Journey Medical Corporation | $14.93 | 2022 | |
| Qiagen, LLC | $13.96 | 2024 | |
| Mayne Pharma Commercial LLC | $13.63 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.53 | 2019 | |
| Merck Sharp & Dohme LLC | $11.53 | 2019 | |
| Biofrontera INC. | $5.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Hirsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.